1. Investor Update esto Charting the path to profitabilityJames A Bi J A. Bianco, M DM.D. Chief Executive Officer 2. Forward Looking Statement This presentation contains…

1. A New Approach to Outsourced Drug Development: How Sponsor-CRO Clinical Delivery Alliances Improve Performance Therapeutic Foresight. Trusted Results. ™ 2. Page 2A New…

HEALTH SCIENCES BRIEFINGS eClinical Visions Clinical Trial Management: Enabling Operational Efficiency Contents: New Challenges Call for Innovative Approaches Rachel Yang,…

1. Introduction to BioprocessingCambridge Healthtech Institute PeptalkPalm Springs, CAPresented by Susan Dana Jones and Sheila MagilBioProcess Technology Consultantswww.bptc.com…

1. Vikas Sinhmar 2K9/BT/8028 2. Various sectors of IBI: 3. CONTENTS:  Drug designing  Tuberculosis - an overview  Target Identification…

HIPAA Compliance and its Relationship to Pharmacovigilance Christi Cordeiro, Project Manager, Life Sciences, Perficient 2 ABOUT PERFICIENT Perficient is a leading information…

Pall Corporation (NYSE: PLL) Analysts Dalton Friedhoff [email protected] Zhendong Jin [email protected] Company Overview Pall Corporation manufactures and…

Headline Goes Here Adding Mass Detection to Routine Peptide Level Biotherapeutic Analysis ©2015 Waters Corporation ‹#› Hello and welcome. I would like to discuss today…

Slide 1 Dynamics Impacting the Future of Healthcare Wendy Mayer & John Cusumano Worldwide Innovation & Business Technology April 10, 2015 1 âOne size fits allâ…

1. 0 Current & Future Trends in Physician E-Sampling %Managing For Superior Sales, Access,Service & Cost BenefitsCopyright © Best Practices®, LLCPhysician E-Sampling…